N-Acetyl-Leucyl-Leucine carries two hydrophobic leucine residues under an N-acetyl cap, forming a stable dipeptide for folding and solubility studies. The sequence models hydrophobic clustering and steric packing. Researchers evaluate its behavior in varied solvent systems. Applications include peptide-assembly modeling, proteolysis research, and structural-biochemistry analysis.
CAT No: R2549
CAS No:24125-26-6
Synonyms/Alias:N-Acetyl-leucyl-leucine;C11333;2-[(2-acetamido-4-methyl-pentanoyl)amino]-4-methyl-pentanoic acid;Acetyl-L-leucyl-L-leucine;AC1L9E2N;2-((2-acetamido-4-methyl-pentanoyl)amino)-4-methyl-pentanoic acid;24125-26-6;CHEBI:7193;SCHEMBL5551895;Q27107453;
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.